Lenvatinib May Up Survival in Anaplastic Thyroid Cancer ...Middle East

Medscape - News
Among patients with unresectable anaplastic thyroid cancer treated with lenvatinib, average survival was prolonged. The study was published as a preprint and has not yet been peer reviewed. First Look

Hence then, the article about lenvatinib may up survival in anaplastic thyroid cancer was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Lenvatinib May Up Survival in Anaplastic Thyroid Cancer )

Apple Storegoogle play

Last updated :

Also on site :